Patent ID: 9402833
Filing Date: 2016-08-02
CPC Classification: A61K,A61P,C07D,Y02A

Claim Text:
1. A method of treating a disease and/or disorder associated with a TrkA kinase activity comprising administering an effective amount of a compound of formula (I), or their pharmaceutically acceptable salts, pharmaceutically acceptable solvates or stereoisomers thereof, wherein A is  X R R when X R R R R R Alternatively R R R R R R m is independently represents 0, 1, 2, 3 or 4; and n is independently represents 0, 1, 2, or 3; wherein the disease and/or disorder is selected from the group consisting of pain, inflammation, cancer, psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, atopic dermatitis, fibrosis, neurodegenerative disease, and